Compare Ikapharmindo Putramas Tbk. (IKPM) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ikapharmindo Putramas Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 313.35B, 1.41M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.2× Ikapharmindo Putramas Tbk.'s market cap, and Ikapharmindo Putramas Tbk. is more actively traded (1.41M versus 635.5K). Which is the better fit depends on your goals.
| IKPM | LABS | |
|---|---|---|
Market Cap | 313.35B | 691.25B |
Volume | 1.41M | 635.5K |
Lot | 14.1K | 6.36K |
Turnover | 271.25M | 110.15M |
Average Price | 192.33 | 173.33 |
Value | 271.25M | 110.15M |
Indicative Equilibrium Price | 186 | 174 |
Indicative Equilibrium Volume | 600 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
